key: cord-0747516-hf5utw4p authors: Liu, Rui; Xu, Xiuying; Zou, Siyun; Li, Yulong; Wang, Huan; Yan, Xiaona; Du, Xiangdong; Zhang, Lan; Zhang, Qinge; Li, Wen; Cheung, Teris; Ungvari, Gabor S.; Ng, Chee H.; Xiang, Yu-Tao title: Prevalence of Suicidality and its Association with Quality of Life in Older Patients with Clinically Stable Psychiatric Disorders in China During the COVID-19 Pandemic date: 2022-03-04 journal: J Geriatr Psychiatry Neurol DOI: 10.1177/08919887221078557 sha: a02e7a41d3912fc55ad4bf52cd97f7c9af2915f9 doc_id: 747516 cord_uid: hf5utw4p AIMS: The pattern of suicidality in older patients with psychiatric disorders during the COVID-19 pandemic is not clear. This study examined the prevalence of suicidality and its association with quality of life (QOL) among older clinically stable patients with psychiatric disorders during the COVID-19 pandemic. METHODS: A multicenter, cross-sectional study was conducted from May 22 to July 15, 2020, among four major tertiary psychiatric hospitals in China. Suicidality was assessed by asking 3 standardized questions. Depressive symptoms, pain, and QOL were assessed with the 9-item Patient Health Questionnaire (PHQ-9), the numeric pain rating scale (NPRS), and the World Health Organization Quality of Life Questionnaire-brief version, respectively. RESULTS: A total of 1063 clinically stable patients participated and completed the assessment. The prevalence of suicidality was 11.8% (95% CI: 9.9%–13.7%) during the COVID-19 pandemic. Multiple logistic regression analysis revealed that poor treatment adherence (P = .009, OR = 1.86, 95% CI: 1.17–2.96) and perceived illness worsening during the COVID-19 outbreak (P = .02, OR = 2.07, 95% CI: 1.15–3.73), being diagnosed with major depressive disorder (P < .001, OR = 2.79, 95% CI: 1.68–4.64), PHQ-9 total score (P < .001, OR = 1.20, 95% CI: 1.15–1.24) and NPRS total score (P = .002, OR = 1.17, 95% CI: 1.06–1.29) were associated with higher risk of suicidality. After controlling for covariates, older psychiatric patients with suicidality had lower QOL compared to those without (F((1, 1063)) =16.5, P<.001). CONCLUSIONS: Suicidality was common in older patients with clinically stable psychiatric disorders during the COVID-19 pandemic. Considering its negative impact on QOL and personal suffering, routine screening and preventive suicide measures should be implemented for older psychiatric patients. Since the Coronavirus disease 2019 (COVID- 19) was first reported in China at the end of 2019, it has been found in more than 200 countries and territories, with more than 15.78 million confirmed cases, 1 and has been declared as a pandemic by the WHO. 2 To reduce the COVID-19 transmission, a range of preventive measures have been implemented in many countries such as lockdown of cities, mass quarantine, and school closure, all of which are associated with increased risk of mental health problems. Vulnerable populations can be affected disproportionately, such as increased suicidality among older adults. [3] [4] [5] Previous studies have noted increased suicide risk among older adults during the 2003 outbreak of severe acute respiratory syndrome (SARS). [6] [7] [8] To date, however, little is known about suicide risk in older adults during the COVID-19 pandemic. Suicidality is a major public health problem worldwide, associated with heavy healthcare burden. 9 ,10 Suicidality consists of several subtypes, including suicidal ideation, suicide plan, and suicide attempt. 11 Older adults, especially older patients with psychiatric disorders, are usually more prone to suicidality. 12, 13 Compared to their younger counterparts, older psychiatric patients are more vulnerable to the effects of the COVID-19 pandemic due to more severe cognitive impairment, poorer self-care, and lack of risk awareness. 14, 15 In China, older patients with stable psychiatric disorders usually visit psychiatric outpatient clinics and receive maintenance treatment. 16 However, during the COVID-19 pandemic, they inevitably experience poorer access to mental health services due to mass quarantine and suspended public transportation in many areas. 5, 16 Although online mental health services and education are provided, many older adults do not use smart phones or benefit from online services/educations as these are not specifically developed for older adults. 16, 17 Further, due to the fear of higher mortality rate of COVID-19 among older population, older patients with psychiatric disorders may be more likely to develop stress, depressive and anxiety symptoms associated with COVID-19, all of which could trigger pre-existing psychiatric disorders and increase the risk of suicidality. 5, 18, 19 As an important measure of health outcome, quality of life (QOL) has been widely used in clinical practice and research. 20, 21 Some studies found that due to lack of social connection, loneliness, and increased psychological problems, older adults had lower QOL during COVID-19. 22, 23 To date, however, no data of suicidality among older patients with psychiatric disorders have been published. Therefore, we conducted this study to examine the prevalence of suicidality and its association with clinical factors and QOL among older patients with clinically stable psychiatric disorders during the COVID-19 pandemic. This was a multicenter, cross-sectional study conducted from May 22 to July 15, 2020. Participants were recruited from 4 major tertiary psychiatric hospitals in northern (Beijing), southern (Fujian province), eastern (Jiangsu province), and western parts (Gansu province) of China, which could represent a wide range of clinical settings. All outpatients who received maintenance therapy for psychiatric disorders diagnosed according to the International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10) 24 were consecutively invited from the outpatient departments of the participating hospitals during the study period if they were (1) aged 50 years and older; (2) judged to be clinically stable by their treating psychiatrists. In this study, patients with changes in doses of psychotropic medications less than 50% during the past three months were defined as "clinically stable"; (3) able to understand the purpose and contents of the assessments and provide written informed consent. Due to the COVID-19 pandemic, face-to-face interviews were not conducted in clinical settings. Instead, data were collected with the WeChat-based Question-Star application (Changsha Renxing Science and Technology, Shanghai, China), which was widely used in China during the COVID-19 pandemic. 25, 26 The WeChat is a mainstream social communication program in China with over 1 billion users. All patients and/or their guardians invited were WeChat users. All patients who agreed to participate in this study were required to complete the assessments with their smartphone. For patients who had difficulties with using smartphone, they could seek help from a research psychiatrist. This study was approved by the -ethics committee of the respective hospitals. A pre-prepared data collection sheet was used to collect patients' basic socio-demographic and clinical characteristics, including age, gender, education years, marital status, household registration (urban/rural residence), severe physical diseases, principal psychiatric diagnosis (major depressive disorder (MDD)/other diagnoses), concern about COVID-19, and frequent use of mass media, limited access to psychiatric services, poor treatment adherence, and perceived illness worsening during the COVID-19 pandemic. Following previous studies, 27,28 suicidality during the COVID-19 outbreak was evaluated by 3 "yes" or "no" standardized questions, including (1) suicidal ideation ("whether you had any suicidal ideation during the COVID-19 outbreak"), (2) suicide plan ("whether you had any suicide plan during the COVID-19 outbreak"), and (3) suicide attempt ("whether you had any suicide attempt during the COVID-19 outbreak"). Patients who responded "yes" to any of the 3 questions were considered "having suicidality." The Chinese version of the 9-item Patient Health Questionnaire (PHQ-9) was used to assess the severity of depression. 29, 30 Each item of PHQ-9 ranges from 0 to 3, and the total score ranges from 0 to 27, with a higher score indicating more severe depression. 29 This scale has been validated and widely used in Chinese populations. 31 The 0-10 numeric pain rating scale (NPRS) was used to assess the level of pain, 32,33 with "0" indicating "no pain" and ten indicating "worst pain imaginable." The Chinese version of NPRS had satisfactory psychometric properties in the elderly. [34] [35] [36] The total score of the first 2 items on overall QOL of the World Health Organization Quality of Life Questionnaire-brief version (WHOQOL-BREF) 37, 38 was used to measure QOL. A higher score means higher QOL. 37 Data analyses were performed using SPSS statistical software version 24.0. To compare the sociodemographical and clinical variables between patients with suicidality and those without, chi-square tests, 2 independent sample t-tests, or Mann-Whitney U tests were used, as appropriate. To explore the independent associated factors of suicidality, multiple logistic regression analysis with "enter" method was performed, with the suicidality as dependent variable, and the variables with significant group differences in univariate analyses as independent variables. Analysis of covariance was conducted to compare QOL between patients with and without suicidality after controlling for variables with significant group difference in univariate analyses. The level of significance was set at P < .05 for all tests (2-sided). Of a total of 1068 patients invited, 1063 met the study entry criteria and completed the assessment. The prevalence of overall suicidality was 11.8% (95% CI: 9.9%-13.7%), with prevalence of suicidal ideation of 11.3% (95% CI: 9.4%-13.2%), suicide plan of 2.8% (95% CI: 1.8%-3.8%), and suicide attempt of 2.6% (95% CI: 1.6%-3.6%). The socio-demographical and clinical characteristics of patients are summarized in Table 1 . Of the patients with suicidality, MDD was the most common psychiatric diagnosis (73.6%; Table 2 ). Univariate analyses found that age, living in rural area, having limited access to psychiatric services, poor treatment adherence, and perceived illness worsening during the COVID-19 outbreak, PHQ-9 total score and NPRS total score were significantly associated with suicidality (all P values <.05). After controlling for covariates, older psychiatric patients with suicidality had lower QOL compared to those without (F (1, 1063) = 16.5, P<.001). Multiple logistic regression analysis found that poor treatment adherence (P = .009, OR = 1.86, 95% CI: 1.17-2.96) and perceived illness worsening during the COVID-19 outbreak (P = .02, OR = 2.07, 95% CI: 1.15-3.73), being diagnosed with MDD (P < .001, OR = 2.79, 95% CI: 1.68-4.64), PHQ-9 total score (P < .001, OR = 1.20, 95% CI: 1.15-1.24), and the NPRS total score (P = .002, OR = 1.17, 95% CI: 1.06-1.29) were significantly associated with higher risk of suicidality (Table 3 ). To the best of our knowledge, this was the first study that examined the prevalence of suicidality in older patients with clinically stable psychiatric disorders and its association with QOL during the COVID-19 outbreak. The prevalence of suicidality (11.8%; 95% CI: 9.9%-13.7%) in this study was substantially higher than previous reports (ie, the 1-year prevalence of suicidality of .009%-.031% in 2018; .009%-.025% in 2017; and .011%-.037% in 2016) among rural older adults in China. [39] [40] [41] Of the older psychiatric patients with suicidality, most reported suicidal ideation, which is a major predictor of future suicide. 42, 43 The prevalence of suicidal ideation among older patients with clinically stable psychiatric disorders in this study (11.3%, 95% CI: 9.4%-13.2%) was even higher than the 1-year prevalence of suicidal ideation (8.8%) among the older adults living in rural areas, 43 the pooled prevalence of suicidal ideation (9.9%) among older adults in China, 44 and the 1-week prevalence of suicidal ideation (3.1%) among the hospitalized older patients with medical conditions in Taiwan. 45 The high prevalence of suicidality in older patients with clinically stable psychiatric disorders could be due to several reasons. First, due to the high risk of mortality and morbidity among older patients infected with COVID-19, many older adults suffered from anxiety and fear of contagion during the COVID-19 pandemic, which may lead to suicidality. 46, 47 Second, mass social isolation and quarantine although being essential public health measures may lead to psychosocial and physical problems, including stress, depression, anxiety, helplessness, and loneliness, which could increase risk for suicidality among older adults. 5, 18, 48, 49 Third, older patients with psychiatric disorders are more vulnerable to poor access to outpatient psychiatric services during the pandemic due to cancellation of appointments, restriction of services, and suspension of public transport, which could increase the risk of relapse of their psychiatric disorders. 16, 18 Fourth, many older patients with psychiatric disorders have major physical co-morbidities 50 which could worsen due to inaccessible medical treatments and in turn may increase the likelihood of suicidality during the COVID-19 pandemic. We found that older psychiatric patients with poor adherence treatment were more likely to experience suicidality during the COVID-19 outbreak, which is consistent with previous findings. [51] [52] [53] Most patients with clinically stable psychiatric disorders need long-term maintenance pharmacotherapy. Poor treatment adherence could lead to exacerbation of psychiatric symptoms, which in turn increases the risk of suicidality. 52, 54 Due to mass lockdowns and quarantine during the pandemic, community mental health services, social supports, and communications with others were severely restricted; therefore, many patients with psychiatric disorders may feel highly stressed and helpless, thereby decreasing their adherence treatment. 55, 56 As expected, patients who experienced illness worsening were at a higher risk of suicidality during the COVID-19 pandemic. 57 Certain psychiatric symptoms, such as depression and anxiety, are closely linked to suicidality. Furthermore, the associated stigma and discrimination of unstable mental illness could lead to severe psychological distress and hence increase the risk of suicidality. 58, 59 Similar to previous findings, [60] [61] [62] we found that patients with a primary diagnosis of MDD and those suffering from severe depressive symptoms had a higher risk of suicidality. Patients with more severe pain symptoms were also at an increased risk of suicidality during the COVID-19. Pain has been considered as a risk factor of suicidality in older adults. 63 Some patients may consider suicide as a means of escape from personal suffering due to intolerable and unbearable pain. [64] [65] [66] We found that older psychiatric patients with suicidality had lower QOL compared to those without, which is partly consistent with previous findings. 62, 67 According to the distress/protection QOL model, 68, 69 QOL is determined by the interaction of distress and protective factors. Suicidality is related to a range of negative health outcomes, for example, worsened psychiatric symptoms, functional impairments, and poor physical health, all of which could lower QOL. The strengths of this study include the large sample size, multicenter design, and the use of standardized instruments. However, several limitations should be noted. First, clinically stable patients were included in this study, limiting the generalizability of the findings to patients in other illness phases. Second, for logistical reasons, some factors associated with suicidality, such as social support, were not examined. Third, the casual relationship between suicidality and other variables could not be examined due to the cross-sectional study design. Finally, suicidality is a spectrum of suicidal behaviors which include suicidal ideation, suicide plan, suicide attempt, and completed suicide. As this study only focused on patients who attended outpatient departments, those who died by suicide were excluded. In conclusion, suicidality was common in older patients with clinically stable psychiatric disorders during the COVID-19 pandemic. Considering the negative impact on QOL and other health outcomes, routine screening and preventive measures of suicide should be implemented for older patients attending outpatient services with pre-existing psychiatric disorders during the COVID-19 pandemic. Specific suicide prevention measures for older psychiatric outpatients may include enhancing adherence to maintenance treatment during the COVID-19 pandemic, and telemedicine which has been widely implemented during the COVID-19 pandemic in China. 5 In addition, community-based mental health services which have been well developed in many areas of China should be integrated into the existing maintenance treatments for psychiatric outpatients in need, especially those with high risk of suicide. 3, 5, 15 Author Contributions The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was supported by the National Science and Technology Major Project for investigational new drug (2018ZX09201-014), the Beijing Municipal Science & Technology Commission (No. Z181100001518005), the University of Macau (MYRG2019-00066-FHS), and the Suzhou Key Medical Center for Psychiatric Diseases (Szzx201509). This study was approved by the ethics committees of the respective hospitals in northern (Beijing), southern (Fujian province), eastern (Jiangsu province), and western parts (Gansu province) of China. All the participants required to be able to understand the purpose and contents of the assessments and provide written informed consent. Rui Liu  https://orcid.org/0000-0001-7613-1144 Qinge Zhang  https://orcid.org/0000-0002-0095-1995 Yu-Tao Xiang  https://orcid.org/0000-0002-2906-0029 World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard World Health Organization. WHO Director-General's Opening Remarks at the Media Briefing on COVID-19 -11 Suicide Mortality and Coronavirus Disease 2019-A Perfect Storm? Suicide risk and prevention during the COVID-19 pandemic COVID-19: the implications for suicide in older adults A revisit on older adults suicides and Severe Acute Respiratory Syndrome (SARS) epidemic in Hong Kong The impact of epidemic outbreak: the case of severe acute respiratory syndrome (SARS) and suicide among older adults in Hong Kong Elderly suicide and the 2003 SARS epidemic in Hong Kong Suicide in the elderly Suicide and suicidal behavior Resilience as a focus of suicide research and prevention Suicide in older adults: nursing assessment of suicide risk Addressing the COVID-19 pandemic in populations with serious mental illness The COVID-19 outbreak and psychiatric hospitals in China: managing challenges through mental health service reform Mental health services for older adults in China during the COVID-19 outbreak The impact of Covid-19 pandemic on elderly mental health Patients with mental health disorders in the COVID-19 epidemic Suicide research and prevention during and after the COVID-19 pandemic Quality of life measurement: bibliographic study of patient assessed health outcome measures Healthrelated quality of life and overall life satisfaction in people with serious mental illness Recovering from the COVID-19 Pandemic: A Focus on Older Adults Social Isolation and Loneliness in Older Adults: Opportunities for the Health Care System World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization Online mental health services in China during the COVID-19 outbreak COVID-19) epidemic on medical staff in different posts in China: a multicenter study Suicidality and clinical correlates in Chinese men who have sex with men (MSM) with HIV infection Prevalence of suicidal ideation and suicide attempts in the general population of China: a meta-analysis The PHQ-9: validity of a brief depression severity measure The reliability and validity of patient helath questionnaire depression module (PHQ-9) in Chinese elderly (in Chinese) Reliability and validity of the Chinese version of the Patient Health Questionnaire (PHQ-9) in the general population Pain in children: comparison of assessment scales Pain assessment Postoperative pain assessment with three intensity scales in Chinese elders The selection of pain intensity assessment scales in Chinese elders (in Chinese) Postoperative pain intensity assessment: a comparison of four scales in Chinese adults Quality of life of Chinese urban community residents: a psychometric study of the mainland Chinese version of the WHOQOL-BREF Measurement and Application of Quality of Life National Health and Family Planning Commission (China). China Health and Family Planning Yearbook National Health and Family Planning Commission (China). China Health and Family Planning Yearbook National Health and Family Planning Commission (China). China Health and Family Planning Yearbook Suicide assessment in hospital emergency departments: implications for patient satisfaction and compliance Suicidal thoughts and behaviors in older adults in rural China: a preliminary study The prevalence of suicide ideation among the Chinese elderly: a meta-analysis Prevalence and characteristics of suicidal ideation among 2199 elderly inpatients with surgical or medical conditions in Taiwan COVID-19 suicidal behavior among couples and suicide pacts: case study evidence from press reports Elderly suicides in India: an emerging concern during COVID-19 pandemic Suicidal behaviour and suicide prevention in later life Social disconnectedness, perceived isolation, and symptoms of depression and anxiety among older Americans (NSHAP): a longitudinal mediation analysis A systematic review of physical illness, functional disability, and suicidal behaviour among older adults Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review Medication adherence in a comparative effectiveness trial for bipolar disorder Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: a systematic review Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment Medication management and adherence during the COVID-19 pandemic: perspectives and experiences from low-and middle-income countries Life event, stress and illness Risk factors for suicide in later life Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry Stigma in mental illness: perspective from eight Asian nations Suicide in older adults: current perspectives Suicide in older adults Issues in research on aging and suicide Pain as a risk factor for suicidal behavior in older adults: a systematic review Understanding suicide among older adults: a review of psychological and sociological theories of suicide Suicide as Psychache: A Clinical Approach to Self-Destructive Behavior Medical illness and the risk of suicide in the elderly Suicidality in middle aged and older patients with schizophrenia and depressive symptoms: relationship to functioning and Quality of Life Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients Satisfaction with quality of life varies with temperament types of patients with schizophrenia